We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$27.1B
AUM Growth
+$1.76B
Cap. Flow
-$1.21B
Cap. Flow %
-4.45%
Top 10 Hldgs %
42.04%
Holding
292
New
14
Increased
41
Reduced
114
Closed
11

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$56.5M
2
RTX icon
RTX Corp
RTX
+$44.9M
3
LLY icon
Eli Lilly
LLY
+$39.2M
4
MA icon
Mastercard
MA
+$24.4M
5
UNH icon
UnitedHealth
UNH
+$14M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$283M
2
TROW icon
T. Rowe Price
TROW
+$142M
3
AAPL icon
Apple
AAPL
+$73.9M
4
PM icon
Philip Morris
PM
+$72.2M
5
CVX icon
Chevron
CVX
+$62.4M

Sector Composition

Rank Sector Weight
1 Technology 19.65%
2 Consumer Staples 19.62%
3 Financials 18.7%
4 Energy 13.49%
5 Healthcare 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DE icon
126
Deere & Co
DE
$167B
$2.95M 0.01%
6,887
– –
EQIX icon
127
Equinix
EQIX
$104B
$2.9M 0.01%
4,423
– –
EMR icon
128
Emerson Electric
EMR
$89B
$2.71M 0.01%
28,162
+800
+3% +$71.9K
NSC icon
129
Norfolk Southern
NSC
$76.7B
$2.62M 0.01%
10,644
– –
IBM icon
130
IBM
IBM
$222B
$2.54M 0.01%
18,049
-6,753
-27% -$932K
CCI icon
131
Crown Castle
CCI
$33.9B
$2.39M 0.01%
17,657
-85
-0.5% -$11.5K
CSCO icon
132
Cisco
CSCO
$480B
$2.23M 0.01%
46,885
-1,672
-3% -$76.1K
DHR icon
133
Danaher
DHR
$137B
$2.21M 0.01%
9,402
– –
RL icon
134
Ralph Lauren
RL
$22.5B
$2.21M 0.01%
20,900
– –
CSX icon
135
CSX Corp
CSX
$94.5B
$2.18M 0.01%
70,404
– –
PAYX icon
136
Paychex
PAYX
$42.2B
$2.14M 0.01%
18,521
– –
IFF icon
137
International Flavors & Fragrances
IFF
$20.7B
$2.09M 0.01%
19,969
+875
+5% +$86K
FOXA icon
138
Fox Class A
FOXA
$24.8B
$2.09M 0.01%
68,658
-12,655
-16% -$386K
BIIB icon
139
Biogen
BIIB
$30.8B
$2.05M 0.01%
7,413
– –
TMO icon
140
Thermo Fisher Scientific
TMO
$209B
$2.05M 0.01%
3,718
– –
REGN icon
141
Regeneron Pharmaceuticals
REGN
$78.3B
$1.91M 0.01%
2,650
+300
+13% +$221K
CVS icon
142
CVS Health
CVS
$133B
$1.84M 0.01%
19,762
+500
+3% +$48.2K
RACE icon
143
Ferrari
RACE
$70.8B
$1.84M 0.01%
8,570
– –
MRSH
144
Marsh
MRSH
$91.4B
$1.79M 0.01%
10,814
-10,400
-49% -$1.7M
GIS icon
145
General Mills
GIS
$19.3B
$1.78M 0.01%
21,184
-438
-2% -$35.7K
CMI icon
146
Cummins
CMI
$87.8B
$1.77M 0.01%
7,318
– –
GD icon
147
General Dynamics
GD
$104B
$1.76M 0.01%
7,083
+2
+0% +$488
LOW icon
148
Lowe's Companies
LOW
$122B
$1.75M 0.01%
8,793
– –
UPS icon
149
United Parcel Service
UPS
$92.7B
$1.71M 0.01%
9,852
– –
CNQ icon
150
Canadian Natural Resources
CNQ
$96.3B
$1.68M 0.01%
60,668
– –
4 5
6
7 8

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Fayez Sarofim & Co held 292 positions worth $27.1B, up 6.9% from $25.3B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co withdrew a net $1.21B in Q4 2022, closing 11 positions and reducing 114 holdings. Its most notable exit was Artisan Partners, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Fayez Sarofim & Co opened a new position in AstraZeneca worth $1.67M.

  • Fayez Sarofim & Co's largest Q4 2022 buy was AstraZeneca: 12,348 shares worth $1.67M.
  • Fayez Sarofim & Co added most to Visa in Q4 2022, an estimated $56.5M increase.
  • Fayez Sarofim & Co's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $283M.
  • Fayez Sarofim & Co fully exited Artisan Partners in Q4 2022, selling an estimated $16.2M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $27.1B portfolio in Q4 2022.
  • Fayez Sarofim & Co opened 14 new positions and closed 11 in Q4 2022.
  • Fayez Sarofim & Co's portfolio value rose 6.9% quarter-over-quarter to $27.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2022, filed 13 Feb 2023.